feed,title,long_url,short_url
BioRxiv,Cell delivery peptides for small interfering RNAs targeting SARS-CoV-2 new variants through a bioinformatics and deep learning design,https://biorxiv.org/cgi/content/short/2022.02.09.479755v1?rss=1,https://bit.ly/34JecbL
BioRxiv,The rise and fall of SARS-CoV-2 variants and the emergence of competing Omicron lineages,https://biorxiv.org/cgi/content/short/2022.02.09.479842v1?rss=1,https://bit.ly/3oEzK08
BioRxiv,SARS-CoV-2 Nsp1 N-terminal and linker regions as a platform for host translational shutoff,https://biorxiv.org/cgi/content/short/2022.02.10.479924v1?rss=1,https://bit.ly/3GH7ujY
BioRxiv,"Remdesivir and GS-441524 retain antiviral activity against Delta, Omicron, and other emergent SARS-CoV-2 variants",https://biorxiv.org/cgi/content/short/2022.02.09.479840v1?rss=1,https://bit.ly/3Lu7kQj
BioRxiv,Dual Inhibition of Cathepsin L and 3CL-Pro by GC-376 Constrains SARS Cov2 Infection Including Omicron Variant,https://biorxiv.org/cgi/content/short/2022.02.09.479835v1?rss=1,https://bit.ly/3rGY9UZ
BioRxiv,Epigenetic Memory of COVID-19 in Innate Immune Cells and Their Progenitors,https://biorxiv.org/cgi/content/short/2022.02.09.479588v1?rss=1,https://bit.ly/3HLnUJd
BioRxiv,Lyophilized mRNA-lipid nanoparticles vaccine with long-term stability and high antigenicity against SARS-CoV-2,https://biorxiv.org/cgi/content/short/2022.02.10.479867v1?rss=1,https://bit.ly/3Jh1Ruk
